Foundation Program Sites

Infectious Disease Management

Award winners for Best Practices in Hepatitis C Virus Care:

Read our Reports and Recommendations

Hepatitis C virus (HCV) is the most common chronic blood-borne pathogen in the US and a leading cause of complications from chronic liver disease. In 2018, an estimated 59,100 Washingtonians were living with HCV, prompting Governor Inslee to issue Directive of the Governor 18-13: “Eliminating Hepatitis C in Washington in 2030 through combined public health efforts and a new medication purchasing approach.”

Read our Charter

Workgroup Members

Name Title Organization
Abha Puri, MPH Program Manager Community Health Plan of Washington
Emalie Huriaux, MPH STD, Adult Hepatitis, and Syringe Service Program (SSP) Manager WA Department of Health
John Scott, MD, MSc Professor, Department of Medicine
Medical Director, Telehealth
Associate Medical Director, Liver Clinic
University of Washington
Jon Stockton, MHA Adult Viral Hepatitis Coordinator WA Department of Health
Judith Tsui, MD, MPH Associate Professor, Department of Medicine
Director, UW Medical Student Addiction Research Program
University of Washington
Melda Velasquez Service Line Director Kadlec Regional Medical Center
Omar Daoud, PharmD Director of Pharmacy Community Health Plan of Washington
Patrick Judkins Education and Outreach Specialist, Disease Control and Prevention Thurston County Health Department
Ryan Pistoresi, PharmD, MS Assistant Chief Pharmacy Officer Washington State Health Care Authority
Wendy Wong, BSc Ambulatory Clinical Pharmacist Providence Health and Services
Vania Rudolph, MD, MPH Addiction Medicine Specialist Swedish Health Centers
Yumi Ando, MD Gastroenterologist Kaiser Permanente

Award winners for Best Practices in Outpatient Infection Control:

Read our Report and Recommendations 

The past several decades have seen a significant shift in healthcare delivery from inpatient to outpatient settings, yet outpatient settings often lack the infrastructure or resources to support infection prevention and surveillance activities. The COVID-19 pandemic has demonstrated the importance of infection control measures, as the first confirmed case in the United States was in Washington, and as of December 2021 over 800,000 Washingtonians have been infected. At the same time, strong infection control policies and procedures like physical distancing and masking have disrupted the circulation of other respiratory viruses and infectious diseases. This workgroup will review existing, often inpatient, infection control guidelines and translate them to outpatient settings.

Read our Charter


Workgroup Members

Name Title Organization
Mark Haugen, MD (chair) Family Medicine Physician Walla Walla Clinic & Surgical Center
Anne Sumner, BSN, MBA VP Head of Operations Baker Boyer Bank
Cathy Carroll Washington Health Care Authority
Faiza Zafar, DO, FACOI Medical Director Community Health Plan of Washington
Larissa Lewis, MPH, CIC HAI Education and Guidance Development Supervisor WA Department of Health
Lisa Hannah, RN, CIC Infection Prevention Team Supervisor WA Department of Health
Lisa Waldowski, DNP, CIC Regional Director, Infection Prevention and Control Kaiser Permanente
Rhonda Bowen, CIC, CPPS, CPHQ Senior Improvement Advisory, Patient Safety Comagine Health
Stephanie Jaross, BSN, RN ASC Director Proliance Center for Outpatient Spine and Joint Surgery
Sierra Bertolone-Smith, MDc Medical Student Pacific Northwest University of Health Sciences